| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/26/2013 | WO2013142124A1 Solid forms of a thiophosphoramidate nucleotide prodrug |
| 09/26/2013 | WO2013141823A1 Modified bordetella pertussis strains |
| 09/26/2013 | WO2013141730A1 Compositions comprising cocktails of antibacterial phages and uses thereof for the treatment of bacterial infections |
| 09/26/2013 | WO2013140919A1 Lps vaccine |
| 09/26/2013 | WO2013140389A1 Plif multimeric peptides and uses thereof |
| 09/26/2013 | WO2013140247A1 Antibodies that neutralize rsv, mpv and pvm and uses thereof |
| 09/26/2013 | WO2013140189A1 6- (4- (1 -amino- 3 -hydroxycyclobutyl) phenyl) - 5 - phenyl (furo, thieno or pyrrolo) [2, 3-d] pyrimidin- 4 - one derivatives for the treatment of cancer |
| 09/26/2013 | WO2013140170A1 Treatment of microbial infections |
| 09/26/2013 | WO2013140148A1 Quinazoline compounds and their use in therapy |
| 09/26/2013 | WO2013139916A1 Vaccine against rsv |
| 09/26/2013 | WO2013139911A1 Vaccine against rsv |
| 09/26/2013 | WO2013139744A1 Method of vaccination against human papillomavirus |
| 09/26/2013 | WO2013139727A1 Triazines with suitable spacers for treatment and/or prevention of hiv infections |
| 09/26/2013 | WO2013139697A1 Conformationally constrained, fully synthetic macrocyclic compounds |
| 09/26/2013 | WO2013139487A1 Flavone derivatives and their use |
| 09/26/2013 | WO2013139300A1 Recombinant lentiviral vector formulation |
| 09/26/2013 | WO2013139206A1 3-oxo-3,4-dihydro-2-pyrazine-formamide derivative, pharmaceutical composition of same, method for preparing same, and use thereof |
| 09/26/2013 | WO2013138951A1 Quinazoline derivate and use thereof as apoptosis inhibitor |
| 09/26/2013 | WO2013138860A1 Antibacterial compounds |
| 09/26/2013 | US20130253073 Photocatalyst composition and preparation for the same |
| 09/26/2013 | US20130252998 Cci-779 formulations for parenteral administration |
| 09/26/2013 | US20130251748 Use of outer membrane porin k36 protein (ompk36) in treatment/prevention/diagnosis of enterobacteriaceae infection |
| 09/26/2013 | US20130251739 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines |
| 09/25/2013 | EP2641914A1 Monoclonal antibody capable of recognizing human papilloma virus (hpv) l2 protein, and method for measuring hpv-neutralizing antibody titer using same |
| 09/25/2013 | EP2641904A1 Flavone derivatives and their use |
| 09/25/2013 | EP2641611A2 Combination therapy |
| 09/25/2013 | EP2641605A1 Novel polymer derivative of cytidine metabolism antagonist |
| 09/25/2013 | EP2640751A1 Lipidated polyepitope vaccines |
| 09/25/2013 | EP2640735A1 Antibacterial amiinoglycoside analogs |
| 09/25/2013 | EP2640729A1 Inhibitors of hiv replication |
| 09/25/2013 | EP2640720A2 Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus |
| 09/25/2013 | EP2640719A2 Antiviral compounds |
| 09/25/2013 | EP2640712A1 2-piperazin-1-yl-4h-1,3-benzothiazin-4-one derivatives and their use for the treatment of mammalian infections |
| 09/25/2013 | EP2640705A2 Novel antiviral compounds |
| 09/25/2013 | EP2640419A1 Respiratory syncytial virus vaccine |
| 09/25/2013 | EP2640418A1 Immunogenic compositions |
| 09/25/2013 | EP2640417A2 Multivalent vaccine for filariasis |
| 09/25/2013 | EP2640415A1 Cross protective epitopes of aspergillus fumigatus and candida albicans |
| 09/25/2013 | EP2640410A1 Composition comprising a peptide and an inhibitor of viral neuraminidase |
| 09/25/2013 | EP2640399A2 Methods and compositions for modulating pd1 |
| 09/25/2013 | EP2640362A1 Therapeutic compositions comprising rilpivirine hcl and tenofovir disoproxil fumarate |
| 09/25/2013 | CN103328476A Optically-active diazabicyclooctane derivative and method for manufacturing same |
| 09/25/2013 | CN103328472A Imidazopyridines as respiratory syncytial virus antiviral agents |
| 09/25/2013 | CN103328466A Novel specific HCV NS3 protease inhibitors |
| 09/25/2013 | CN103328441A Process for the manufacture of ajoene derivatives |
| 09/25/2013 | CN103327999A Composition for promoting lipolysis |
| 09/25/2013 | CN103327984A Injectable compositions for mastitis comprising an NSAID and an antibiotic in a non-aqueous solvent |
| 09/25/2013 | CN103320482A Polar region Pseudoalteromonas elyakovii exopolysaccharide and application thereof in aquaculture |
| 09/25/2013 | CN103320451A Genetic engineering protein vaccine for preventing EV71, and preparation method thereof |
| 09/25/2013 | CN103320412A Application of deep-sea lysozyme in inhibiting medicament-resistant staphylococcus aureus |
| 09/25/2013 | CN103320394A Method for preparing virus-like particle and recombinant baculovirus used therein |
| 09/25/2013 | CN103320365A Fish-sourced aeromonas hydrophila disease antagonistic strain and application thereof |
| 09/25/2013 | CN103320349A Bacillus sp. S-2-6 and bacterial inhibition use thereof |
| 09/25/2013 | CN103320345A Bdellovibrio bacteriovorus preparation, and fermentation method and applications thereof |
| 09/25/2013 | CN103320344A Bdellovibrio bacteriovorus preparation, and fermentation method and applications thereof |
| 09/25/2013 | CN103320343A Bdellovibrio bacteriovorus preparation, and fermentation method and applications thereof |
| 09/25/2013 | CN103320342A Bdellovibrio bacteriovorus preparation, and fermentation method and applications thereof |
| 09/25/2013 | CN103320341A Bdellovibrio bacteriovorus preparation, and fermentation method and applications thereof |
| 09/25/2013 | CN103320340A Bdellovibrio bacteriovorus preparation, and fermentation method and applications thereof |
| 09/25/2013 | CN103319604A Human rotavirus Delta VP8* subunit recombinant protein and application thereof |
| 09/25/2013 | CN103319602A 疫苗载体 Vaccine vector |
| 09/25/2013 | CN103319601A 疫苗载体 Vaccine vector |
| 09/25/2013 | CN103319593A Anti StxII monoclonal antibody |
| 09/25/2013 | CN103319586A Antimicrobial peptide MP1102 of anti-drug resistance staphylococcus aureus and preparation method and application thereof |
| 09/25/2013 | CN103319579A Protein AFLA-216 associated with azole drug sensitivity in aspergillus flavus as well as encoding gene and application thereof |
| 09/25/2013 | CN103319577A Haemophilus parasuis (Hps) immunoprotecive antigen OppA |
| 09/25/2013 | CN103319576A Haemophilus parasuis (Hps) immunoprotecive antigen AfuA |
| 09/25/2013 | CN103319575A Haemophilus parasuis (Hps) immunoprotecive antigen CdtB |
| 09/25/2013 | CN103319573A Method for producing classical swine fever virus subunit vaccine by utilizing bombyx mori bioreactor |
| 09/25/2013 | CN103319568A Non-protein amino acid antibacterial peptide and application for same |
| 09/25/2013 | CN103319554A Modified 2' and 3' -nucleoside produgs for treating flaviridae infections |
| 09/25/2013 | CN103319508A Cellular structural supramolecular compound with drug molecule serving as ligand and preparation method of cellular structural supramolecular compound |
| 09/25/2013 | CN103319496A Polycyclic polyketone compounds from marine verrucosispora sp., and preparation method and application thereof |
| 09/25/2013 | CN103319494A Dihydronaphthalene ketone derivative and preparation method and applications thereof |
| 09/25/2013 | CN103319479A Rheinic acid berberine ion pair compound, preparation method and applications |
| 09/25/2013 | CN103319464A 病毒聚合酶抑制剂 Viral polymerase inhibitors |
| 09/25/2013 | CN103319463A N1-substituted 3,4-dihydropyrimidine-2-ketone-C60 compound and preparation method thereof |
| 09/25/2013 | CN103319443A Dihydronaphthalene ketone compound and preparation method and applications thereof |
| 09/25/2013 | CN103319437A Pleuromutilin derivative with thiadiazole skeleton, as well as preparation method and applications thereof |
| 09/25/2013 | CN103319430A Pinane-based isoxazoline compound as well as synthesis method and application thereof |
| 09/25/2013 | CN103319367A Caproamide derivative, and preparation method, intermediate and application thereof |
| 09/25/2013 | CN103316358A Bivalent DNA (Deoxyribonucleic Acid) vaccine and preparation method thereof |
| 09/25/2013 | CN103316357A Recombinant influenza virus chimeric vaccine carrying RSV gene, and preparation method thereof |
| 09/25/2013 | CN103316356A Recombinant lentivirus vector preparation |
| 09/25/2013 | CN103316355A Pseudorabies live vaccine and preparation method thereof |
| 09/25/2013 | CN103316353A Ice laser treatment device carrier liquid and preparation method thereof |
| 09/25/2013 | CN103316350A Gatifloxacin and sodium chloride injection and its preparation method |
| 09/25/2013 | CN103316339A Hepatitis b vaccine for low and non response people and preparation method thereof |
| 09/25/2013 | CN103316338A Health-care immunization needle injection method of piglet |
| 09/25/2013 | CN103316337A Construction of vaccinia virus vector gene modification system, and application of recombinant coronavirus |
| 09/25/2013 | CN103316336A Rotavirus vaccine for oral administration |
| 09/25/2013 | CN103316335A Poliovirus vaccine for oral administration |
| 09/25/2013 | CN103316334A Infectious bursal disease live vaccine and production method thereof |
| 09/25/2013 | CN103316330A Formula and purposes of soft tissue trauma nursing material |
| 09/25/2013 | CN103316314A Muscle and bone joint dredging paste |
| 09/25/2013 | CN103316301A Method for removing bitter taste of turmeric |
| 09/25/2013 | CN103316278A Traditional Chinese medicine for treating herpes zoster |
| 09/25/2013 | CN103316266A Chinese herbal medicine antibacterial lotion and preparation technology thereof |
| 09/25/2013 | CN103316262A Gynecological external antibacterial liquid and preparation method thereof |
| 09/25/2013 | CN103316261A Medical antibacterial liquid and preparation method thereof |